A newly identified molecule called OLE helped restore the brain’s immune cells to a more protective state in Alzheimer’s ...
Esketamine, commonly used to treat treatment-resistant depression, has pharmacological mechanisms that remain incompletely understood. Brain organoids offer a human-relevant platform for investigating ...
Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, which are infection and tumor-fighting white blood cells, so that they have a ...
Hypoglycemia is a frequent and potentially severe complication that can result in significant brain injury in individuals with diabetes treated with insulin or other hypoglycemic agents and in those ...
Scientists at the University of Cambridge believe they may have discovered a surprising new way to slow the spread of brain cancer. Instead of targeting cancer cells directly, their research suggests ...
A mechanism underlying neutrophil reprogramming in brain cancers has been uncovered, illuminating potential therapeutic targets to stop their pro-cancer effect. Tumor-infiltrating neutrophils are ...
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
The lab of Filippo Veglia, Ph.D., at The Wistar Institute has discovered a previously unknown mechanism for how aggressive brain cancers reprogram immune system cells from fighting cancer to enabling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results